drugset / Trial / NCT04414813
Stereotactic Transplantation of hAESCs for Parkinson's Disease
Phase 0
Completed
3 enrolled
Shanghai East Hospital
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of stereotactic transplantation of hAESCs for Parkinson's disease.
Timeline
- Start
- 2020-10-08
- Primary completion
- 2023-02-08
- Completion
- 2023-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Amniotic Epithelial Stem Cells | Unknown | 5e+07 cells | Other |